Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;28(1):101-113.
doi: 10.1089/ten.TEB.2020.0246. Epub 2021 Mar 9.

Exosomes: A Tool for Bone Tissue Engineering

Affiliations
Review

Exosomes: A Tool for Bone Tissue Engineering

Julika Huber et al. Tissue Eng Part B Rev. 2022 Feb.

Abstract

Mesenchymal stem cells (MSCs) have been repeatedly shown to be a valuable source for cell-based therapy in regenerative medicine, including bony tissue repair. However, engraftment at the injury site is poor. Recently, it has been suggested that MSCs and other cells act through a paracrine signaling mechanism. Exosomes are nanostructures that have been implicated in this process. They carry DNA, RNA, proteins, and lipids and play an important role in cell-to-cell communication directly modulating their target cell at a transcriptional level. In a bone microenvironment, they have been shown to increase osteogenesis and osteogenic differentiation in vivo and in vitro. In the following review, we will discuss the most advanced and significant knowledge of biological functions of exosomes in bone regeneration and their clinical applications in osseous diseases. Impact statement Mesenchymal stem cells have been shown to be a promising tool in bone tissue engineering. Recently, it has been suggested that they secrete exosomes containing messenger RNA, proteins, and lipids, thus acting through paracrine signaling mechanisms. Considering that exosomes are nonteratogenic and have low immunogenic potential, they could potentially replace stem-cell based therapy and thus eradicate the risk of neoplastic transformation associated with cell transplantations in bone regeneration.

Keywords: bone defect; bone tissue engineering; exosomes; mesenchymal stromal cells; regenerative medicine.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

FIG. 1.
FIG. 1.
Schematic of the biogenesis of exosomes. Invagination of the plasma membrane to form early endosomes. Involving the Golgi apparatus, DNA, RNA, proteins, and lipids are incorporated by invagination of the endosomal membrane to form late endosomes. A multivesicular body is formed containing multiple intraluminal vesicles. The multivesicular body is either processed by lysosomes for degradation or fuses with the cell plasma membrane to release the intraluminal vesicles, now called exosomes, into the extracellular space. This process is called exocytosis. ER, endoplasmatic reticulum; ILV, intraluminal vesicle; MVB, multivesicular body.

References

    1. O'Keefe, R.J., and Mao, J.. Bone tissue engineering and regeneration: from discovery to the clinic—an overview. Tissue Eng Part B Rev 17, 389, 2011. - PMC - PubMed
    1. González Díaz, E.C., Shih, Y.V., Nakasaki, M., Liu, M., and Varghese, S.. Mineralized biomaterials mediated repair of bone defects through endogenous cells. Tissue Eng A 24, 1148, 2018. - PMC - PubMed
    1. Amini, A.R., Laurencin, C.T., and Nukavarapu, S.P.. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng 40, 363, 2012. - PMC - PubMed
    1. Tan, S.H.S., Wong, J.R.Y., Sim, S.J.Y., et al. Mesenchymal stem cell exosomes in bone regenerative strategies-a systematic review of preclinical studies. Mater Today Bio 7, 100067, 2020. - PMC - PubMed
    1. Baroli, B. From natural bone grafts to tissue engineering therapeutics: brainstorming on pharmaceutical formulative requirements and challenges. J Pharm Sci 98, 1317, 2009. - PubMed

Publication types

LinkOut - more resources